|
V.V. Fomin
Opening Remarks
|
|
|
T.E. Polunina
CHRONIC HEPATITIS C VIRUS IN TERMS OF MODERN RUSSIAN AND EUROPEAN RECOMMENDATIONS
|
9-15 |
|
I.G. Nikitin, I.E. Baykova, V.A. Kislyakov, L.M. Gogova, V. M. Volynkina
OUTSTANDING ISSUES IN THE TREATMENT OF CHRONIC HEPATITIS B
|
16-20 |
|
Yu.A. Kucheryavy, A.V. Smirnov, R.T. Dzhavatkhanova, N.N. Ustinov
MECHANISMS OF PAIN IN CHRONIC PANCREATITIS: WHAT DRUG SHOULD BE PRESCRIBED BY MEDICAL PRACTITIONER AND FOR WHOM?
|
21-27 |
|
A.I.Aminova, S.I.Erdes
CONSTIPATION IN INFANTS: PROBLEM SOLUTION FROM THE POSITION OF EVIDENCE BASED MEDICINE
|
28-33 |
|
E.A.Belousova
RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF CROHN’S DISEASE IN ADULT PATIENTS (2013)
|
34-43 |
|
N.A. Agafonova, E.P. Yakovenko, A.V. Yakovenko, A.S. Pryanishnikova, A.V. Kovtun, Y.V. Grigoryeva, T.V. Volosheynikova, A.N. Ivanov
THE USE OF ENZYMATIC PREPARATIONS IN CLINICAL PRACTICE
|
44-48 |
|
A.V. Kalinin
NEUROENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT AND PANCREAS AS GASTROENTEROLOGICAL A PROBLEM
|
49-55 |
|
T.R. Kameneva, M.V. Zhuravleva, O.A. Rogacheva
CURRENT ISSUES OF RATIONAL PHARMACOTHERAPY OF COMORBID CONDITIONS
|
56-61 |
|
R. S. Oskanova, L.Yu.Ilchenko, I.G.Fedorov
CHRONIC HEPATIC DISEASES: FROM PATHOGENESIS TO TREATMENT
|
62-65 |
|
E.Yu.Plotnikova, E.N. Baranova
COMBINATION OF CELIAC DISEASE, LACTASE DEFICIENCY AND BACTERIAL OVERGROWTH SYNDROME, NEWLY DIAGNOSED IN WOMAN 35 YEARS OLD
|
66-69 |
|
O.S. Gundobina
GAUCHER DISEASE IN CHILDREN: MAJOR ASPECTS
|
70-73 |
|
A.V. Russkikh
MODERN METHODS OF DIAGNOSIS OF VIRAL HEPATITIS
|
74-78 |
|
O.O. Znoiko, E.A. Klimova, S.L. Maksimov, M.V. Maevskaya, S.N. Kizhlo, N.A. Petrochenkova, F.I. Nagimova, Yu.N. Linkova
EFFICIENCY OF CEPEGINTERFERON ALPHA-2B IN THE TREATMENT OF CHRONIC HEPATITIS C
|
79-84 |
|
A.M. Shilov, O.A. Zorina, N.B. Petrukhina
INTESTINAL DYSBIOSIS, PERIODONTITIS AND METABOLIC-ASSOCIATED CARDIOVASCULAR DISEASES
|
85-91 |
|
O.N. Minushkin, L.V. Maslovsky, A.G. Shuleshova, Z.N. Golikova
TREATMENT AND PREVENTION OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ANTIPLATELET/ANTICOAGULANT THERAPY
|
92-97 |
|
O.N. Minushkin, L.V. Maslovsky, A.A. Frolova
LIVER CIRRHOSES: EPIDEMIOLOGICAL AND PROGNOSTIC ASPECTS
|
98-103 |
Русский
